Multiple sclerosis and the importance of neurofilament light chains (Nf-L)
Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system. The exact cause has not been conclusively clarified. However, it is generally assumed to be a misdirected immune reaction against CNS structures, with genetic and environmental factors playing a role.
Symptoms and progression vary greatly from individual to individual. This makes diagnosis difficult and makes an early, reliable assessment of disease activity particularly important. This is where neurofilament light chains (Nf-L) come into play. These are structural proteins of the axon that are released when damage occurs and can be measured both in the cerebrospinal fluid and - in much lower concentrations - in the serum. Modern, highly sensitive methods now allow reliable determination in the blood.
What does this mean for everyday clinical practice?
- Elevated Nf-L levels are an indicator of neuroaxonal damage. They occur in MS, Alzheimer's disease or after traumatic brain injuries, among others.
- In MS, Nf-L concentrations are higher than in healthy people. They correlate with disease activity, the occurrence of relapses, MRI lesions and the response to treatment. Subclinical disease activity that is not visible on MRI can also be detected.
- Nf-L values decrease during effective treatment, while they remain elevated if disease activity persists. This makes them suitable for estimating the prognosis and for monitoring the course of therapy.
It is important to note: Nf-L are not specific to MS, but occur in various neurological diseases. As the determination in serum is minimally invasive, it is suitable for monitoring.